Last reviewed · How we verify
Sedative analgesia/muscle relaxant therapy
Sedative analgesia/muscle relaxant therapy combines central nervous system depressants and analgesics to produce sedation, pain relief, and muscle relaxation for clinical use.
Sedative analgesia/muscle relaxant therapy combines central nervous system depressants and analgesics to produce sedation, pain relief, and muscle relaxation for clinical use. Used for Perioperative sedation and analgesia, Intensive care unit sedation and analgesia, Procedural sedation with muscle relaxation.
At a glance
| Generic name | Sedative analgesia/muscle relaxant therapy |
|---|---|
| Also known as | Propofol, midazolam, dexmedetomidine |
| Sponsor | Second Affiliated Hospital, School of Medicine, Zhejiang University |
| Modality | Small molecule |
| Therapeutic area | Anesthesia/Critical Care |
| Phase | FDA-approved |
Mechanism of action
This is a therapeutic approach rather than a single drug entity, typically combining sedatives (such as benzodiazepines or propofol), opioid analgesics, and muscle relaxants (such as neuromuscular blocking agents) to achieve simultaneous sedation, analgesia, and skeletal muscle relaxation. The combination allows for reduced dosing of individual agents while achieving the desired clinical endpoints in perioperative or critical care settings.
Approved indications
- Perioperative sedation and analgesia
- Intensive care unit sedation and analgesia
- Procedural sedation with muscle relaxation
Common side effects
- Respiratory depression
- Hypotension
- Bradycardia
- Delayed emergence from anesthesia
- Postoperative nausea and vomiting
Key clinical trials
- Mode of Sedation During Endovascular Treatment of Vertebrobasilar Stroke (NA)
- Platform Adaptive Embedded Trial for Acute Respiratory Distress Syndrome (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: